Prostate Cancer News Today

February 25, 2021February 25, 2021

Cancer-sniffing Dogs May Help Train Robot Noses to Detect Tumors Early

Prostate Cancer News Today

Understanding the molecular components of odors used by trained dogs to detect prostate cancer could help researchers to develop computers with similar diagnostic accuracy, a new study shows. The study, ... Read more

February 23, 2021February 23, 2021

Prolaris Test Helps ID Higher-risk Patients Who May Safely Skip ADT

Prostate Cancer News Today

Prolaris — a genetic test that predicts the aggressiveness of prostate cancer — can accurately identify which men with intermediate- or high-risk disease will benefit from adding androgen deprivation therapy (ADT) ... Read more

February 18, 2021February 18, 2021

Erleada-Zytiga Combo Delays Progression in mCRPC Patients, Phase 3 Trial Reports

Prostate Cancer News Today

Combining Erleada (apalutamide) and Zytiga (abiraterone acetate) to treat metastatic castration-resistant prostate cancer (mCRPC) significantly extends the time patients live without signs of disease worsening, compared with Zytiga alone, Janssen announced ... Read more

February 16, 2021February 16, 2021

Erleada-ADT Combo Found to Prolong Survival, Delay Cancer Worsening

Prostate Cancer News Today

When given in combination with androgen deprivation therapy or ADT, Erleada (apalutamide) significantly prolonged the lives of men with metastatic hormone-sensitive prostate cancer (mHSPC) — without compromising their quality of ... Read more

February 11, 2021February 11, 2021

‘TRUE Love’ Contest Calls for Entries Honoring Caregivers

Prostate Cancer News Today

With help from actress Kristen Bell, the Prostate Cancer Foundation (PCF) has opened its 4th annual TRUE Love contest for entries that pay tribute to family members and caregivers of ... Read more

February 10, 2021February 10, 2021

New AI Tool May Better Predict Relapse After Surgery

Prostate Cancer News Today

Researchers have developed an artificial intelligence (AI) tool that shows the potential to predict prostate cancer aggressiveness and the likelihood of post-surgery relapse more accurately than standard methods can. Called ... Read more

February 4, 2021February 4, 2021

Dosing Begins in Phase 1 Trial of FT-7051 for Advanced, Resistant Cancer

Prostate Cancer News Today

Dosing has begun in a Phase 1 clinical trial testing Forma Therapeutics’ investigational therapy FT-7051 in people with metastatic castration-resistant prostate cancer (mCRPC). Recruiting at sites in Arizona and South Carolina, ... Read more

February 2, 2021February 2, 2021

NBA Teams Join Efforts to Raise Money and Awareness

Prostate Cancer News Today

The Prostate Cancer Foundation (PCF) and several NBA teams are joining efforts to raise money and awareness for prostate cancer research throughout February. Various national basketball teams, including the Atlanta ... Read more

January 28, 2021January 28, 2021

Biological Clock Protein CRY-1 Eyed as Therapeutic Target

Prostate Cancer News Today

CRY-1, a regulator of our circadian clocks, contributes to disease spread and poor outcomes in prostate cancer patients by boosting DNA repair mechanisms that render cells more resistant to treatments, a ... Read more

January 26, 2021January 26, 2021

EPI-7386 Combo Therapies Enter Trial for Certain mCRPC Patients

Prostate Cancer News Today

Essa Pharma has entered a clinical collaboration with Janssen to evaluate its small molecule inhibitor EPI-7386, in combination with either Erleada (apalutamide) or Zytiga (abiraterone acetate) plus prednisone, for patients with ... Read more

January 21, 2021January 21, 2021

Daily Coffee Drinking Lowers Prostate Cancer Risk, Study Suggests

Prostate Cancer News Today

Drinking more coffee may significantly reduce a person’s risk of prostate cancer, with a nearly 1% lesser likelihood seen with each additional daily cup of coffee consumed, an analysis of ... Read more

January 19, 2021January 19, 2021

Active Surveillance Safe for Black Men With Low-risk Diagnosis, Study Finds

Prostate Cancer News Today

Offering Black men active surveillance to manage low-risk prostate cancer is safe and does not increase the risk of disease spreading or death more than it does for white men, ... Read more

January 14, 2021January 14, 2021

Nubeqa Prescribing Information Updated With New Survival Data

Prostate Cancer News Today

The prescribing information for Nubeqa (darolutamide) — used to treat men with prostate cancer that has not spread to other parts of the body — will be updated to include ... Read more

January 12, 2021January 12, 2021

Orgovyx Now Available in US for Advanced Prostate Cancer

Prostate Cancer News Today

A couple of weeks after its approval, Orgovyx (relugolix) is now commercially available in the U.S. for adults with advanced prostate cancer through authorized specialty distributors, the therapy’s developer, Myovant ... Read more

January 7, 2021January 7, 2021

Oral ARV-110 Shows Promise in Heavily Treated mCRPC Patients

Prostate Cancer News Today

ARV-110, an investigational oral therapy that degrades the androgen receptor, has a favorable safety profile and showed promising anti-tumor activity in heavily pretreated men with metastatic castration-resistant prostate cancer (mCRPC), ... Read more